What is Capricor Therapeutics's operating lease ROU assets?

Capricor Therapeutics (CAPR) reported operating lease ROU assets of $13.16M in Q1 2026.

How has Capricor Therapeutics's operating lease ROU assets changed year-over-year?

Capricor Therapeutics's operating lease ROU assets increased by 1066.8% year-over-year, from $1.13M to $13.16M.

What does operating lease ROU assets mean?

Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Capricor Therapeutics CAPR Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Sarepta Therapeutics, Inc.SRPT

$124.06M-15.6%

PTC TherapeuticsPTCT

$76.69M+33.8%

Celldex TherapeuticsCLDX

$2.01M-42.7%

VericelVCEL

$63.41M-7.7%

Dyne Therapeutics, Inc.DYN

$19.65M-17.7%

Viridian Therapeutics, Inc.VRDN

$2.26M+2,424,731,083%

Other financials

Income statement

See full

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

See full

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

See full

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

See full

Market cap$1.71B+303%

Profitability

See full

Operating margin-778.8%-1,038pp

Net margin-736.6%-981pp

FCF margin-563.9%-954pp

Returns & leverage

See full

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Capricor Therapeutics's operating lease ROU assets?: Capricor Therapeutics (CAPR) reported operating lease ROU assets of $13.16M in Q1 2026.
How has Capricor Therapeutics's operating lease ROU assets changed year-over-year?: Capricor Therapeutics's operating lease ROU assets increased by 1066.8% year-over-year, from $1.13M to $13.16M.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.